Loading…

Decreased expression of the NADH:ubiquinone oxidoreductase (complex I) subunit 4 in 1-methyl-4-phenylpyridinium -treated human neuroblastoma SH-SY5Y cells

Oxidative stress and mitochondrial dysfunction have been implicated in Parkinson's disease (PD) pathology. NADH:ubiquinone oxidoreductase (complex I) (EC 1.6.99.3) enzyme activity is aberrant in both PD and 1-methyl-4-phenylpyridinium (MPP +) models of PD. Reverse transcription polymerase chain...

Full description

Saved in:
Bibliographic Details
Published in:Neuroscience letters 2001-06, Vol.306 (3), p.145-148
Main Authors: Conn, Kelly J, Ullman, M.David, Eisenhauer, Patricia B, Fine, Richard E, Wells, John M
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Oxidative stress and mitochondrial dysfunction have been implicated in Parkinson's disease (PD) pathology. NADH:ubiquinone oxidoreductase (complex I) (EC 1.6.99.3) enzyme activity is aberrant in both PD and 1-methyl-4-phenylpyridinium (MPP +) models of PD. Reverse transcription polymerase chain reaction of RNA isolated from MPP +-treated human neuroblastoma SH-SY5Y cells identified changes in steady-state mRNA levels of the mitochondrial transcript for subunit 4 of complex I (ND4). Expression of ND4 decreased to nearly 50% after 72 h of MPP + (1 mM) exposure. The expression of other mitochondrial transcripts did not change significantly under the same conditions. Pre-incubation of cells with the free-radical spin-trap, N-tert-butyl-α-(2-sulfophenyl)-nitrone prior to MPP + exposure, prevented decreases in cell viability and ND4 expression. This suggests that functional defects in complex I enzyme activity in PD and MPP + toxicity may result from changes in steady-state mRNA levels and that free radicals may be important in this process.
ISSN:0304-3940
1872-7972
DOI:10.1016/S0304-3940(01)01888-2